Acute Effects of Inspiratory Muscle Warm-up on Muscular Performance and Pulmonary Function in Natural Bodybuilders
IWU and 1RM
1 other identifier
interventional
27
1 country
1
Brief Summary
The present study aims to investigate the acute effects of inspiratory muscle warm-up (IWU) on 1RM performance in professional natural bodybuilders. The hypothesis is that IWU will lead to an increase in the pressure-generating capacity of the inspiratory muscles, thereby resulting in improved 1RM strength performance. The anticipated findings are expected to contribute not only to the enhancement of maximal strength performance but also to the improvement of exercise efficiency through increased respiratory muscle endurance. It is submitted that these outcomes may ultimately provide insights into the long-term sustainability of professional athletes' performance. Twenty male athletes who had competed in national and international professional natural bodybuilding competitions were recruited for this study. The participants had an average experience in natural bodybuilding of 3.21 years, with a standard deviation of ± 1.44 years, and trained for more than five hours per week. The data collection period commenced in July 2025. The study was designed as a randomized controlled experimental trial. Participants were randomly assigned to two groups by a computerized program at three visits after the trial, based on their first measurement: inspiratory warm-up (IWU) group or control (CON) group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2026
CompletedFirst Submitted
Initial submission to the registry
January 18, 2026
CompletedFirst Posted
Study publicly available on registry
February 5, 2026
CompletedMay 7, 2026
May 1, 2026
3 months
January 18, 2026
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
1RM
One-Repetition maximum (1RM) bench press performance
Day 1
maximal inspiratory pressures (MIP )
maximal inspiratory pressures (MIP )
Day 1
Secondary Outcomes (5)
maximal expiratory pressures (MEP)
Day 1
Forced vital capacity (FVC)
Day 1
forced expiratory volume in one second (FEV1)
Day 1
FEV1/FVC ratio (Tiffeneau index)
Day 1
peak expiratory flow (PEF)
Day 1
Study Arms (2)
IWU
OTHERThe IWU group performed both inspiratory muscle warm-up and standard exercise warm-up.
Control Group
OTHERThe CON group performed only the standard warm-up.
Interventions
Eligibility Criteria
You may qualify if:
- They were professional natural bodybuilders with less than three years of experience. ,
- Male professional natural bodybuilders aged 18-35 years
- Full participation in training and matches during the previous 6 months,
- Ability to perform maximal exercise testing
You may not qualify if:
- Individuals were deemed ineligible on the basis of a medical history that included any chronic or acute respiratory disease.
- Individuals were considered ineligible if they were taking any prescription medication that could affect their response to exercise.
- In accordance with the stipulated criteria, individuals were deemed to be ineligible for participation in the study if they had a history of current smoking or had smoked within the past year.
- Individuals were considered ineligible for participation in the study if they had participated in similar studies within the previous six months.
- Prior to participation, all individuals were required to sign a formal waiver, thereby affirming their adherence to the World Anti-Doping Agency Code.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gümüşhane Universıtylead
- Çankırı Karatekin Universitycollaborator
Study Sites (1)
Gumushane Univetsity
Gümüşhane, Gümüşhane Province, (542) 442-7444, Turkey (Türkiye)
Study Officials
- STUDY CHAIR
Coşkun YILMAZ, associate professor
Gümüşhane Üniversity
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ASSOC. PROF.
Study Record Dates
First Submitted
January 18, 2026
First Posted
February 5, 2026
Study Start
January 5, 2025
Primary Completion
April 15, 2025
Study Completion
January 5, 2026
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the dataset consists of a small sample of elite athletes, and sharing de-identified data could still pose a risk of participant re-identification. In addition, no data-sharing agreement or participant consent for IPD sharing was established at the time of study design. Aggregate data supporting the findings are reported within the published article.